Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients.

Wang X, Ring BZ, Seitz RS, Ross DT, Woolf K, Beck RA, Hicks DG, Yeh S.

BMC Clin Pathol. 2015 Dec 9;15:21. doi: 10.1186/s12907-015-0021-5. eCollection 2015.

2.

EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.

Berlin MS, Rowe-Rendleman C, Ahmed I, Ross DT, Fujii A, Ouchi T, Quach C, Wood A, Ward CL.

Br J Ophthalmol. 2016 Jun;100(6):843-7. doi: 10.1136/bjophthalmol-2015-307000. Epub 2015 Oct 9.

3.

Global gene expression analysis reveals a link between NDRG1 and vesicle transport.

Askautrud HA, Gjernes E, Gunnes G, Sletten M, Ross DT, Børresen-Dale AL, Iversen N, Tranulis MA, Frengen E.

PLoS One. 2014 Jan 31;9(1):e87268. doi: 10.1371/journal.pone.0087268. eCollection 2014.

4.

Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study.

Bartlett JM, Bloom KJ, Piper T, Lawton TJ, van de Velde CJ, Ross DT, Ring BZ, Seitz RS, Beck RA, Hasenburg A, Kieback D, Putter H, Markopoulos C, Dirix L, Seynaeve C, Rea D.

J Clin Oncol. 2012 Dec 20;30(36):4477-84. doi: 10.1200/JCO.2012.42.8896. Epub 2012 Oct 8.

PMID:
23045591
5.

TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinoma.

Samimi G, Ring BZ, Ross DT, Seitz RS, Sutherland RL, O'Brien PM, Hacker NF, Huh WK.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):273-9. doi: 10.1158/1055-9965.EPI-11-0917. Epub 2011 Dec 22.

6.

Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.

Shon W, Jenkins SM, Ross DT, Seitz RS, Beck RA, Ring BZ, Okuno SH, Gibson LE, Folpe AL.

J Cutan Pathol. 2011 Dec;38(12):961-6. doi: 10.1111/j.1600-0560.2011.01790.x.

PMID:
22050093
7.

Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.

Bartlett JM, Thomas J, Ross DT, Seitz RS, Ring BZ, Beck RA, Pedersen HC, Munro A, Kunkler IH, Campbell FM, Jack W, Kerr GR, Johnstone L, Cameron DA, Chetty U.

Breast Cancer Res. 2010;12(4):R47. doi: 10.1186/bcr2604. Epub 2010 Jul 8.

8.

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence.

Hicks DG, Janarthanan BR, Vardarajan R, Kulkarni SA, Khoury T, Dim D, Budd GT, Yoder BJ, Tubbs R, Schreeder MT, Estopinal NC, Beck RA, Wang Y, Ring BZ, Seitz RS, Ross DT.

BMC Cancer. 2010 Mar 22;10:108. doi: 10.1186/1471-2407-10-108.

9.

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression.

Sridhar K, Ross DT, Tibshirani R, Butte AJ, Greenberg PL.

Blood. 2009 Nov 26;114(23):4847-58. doi: 10.1182/blood-2009-08-236422. Epub 2009 Oct 2.

10.

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, Arbogast S, Robert F, Schreeder MT, Ross DT.

Mod Pathol. 2009 Aug;22(8):1032-43. doi: 10.1038/modpathol.2009.60. Epub 2009 May 8.

11.

TLE3 as a candidate biomarker of response to taxane therapy.

Kulkarni SA, Hicks DG, Watroba NL, Murekeyisoni C, Hwang H, Khoury T, Beck RA, Ring BZ, Estopinal NC, Schreeder MT, Seitz RS, Ross DT.

Breast Cancer Res. 2009;11(2):R17. doi: 10.1186/bcr2241. Epub 2009 Mar 23.

12.

Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function.

Haines CJ, Giffon TD, Lu LS, Lu X, Tessier-Lavigne M, Ross DT, Lewis DB.

J Exp Med. 2009 Feb 16;206(2):275-85. doi: 10.1084/jem.20080996. Epub 2009 Jan 26.

13.

Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.

Ross DT, Kim CY, Tang G, Bohn OL, Beck RA, Ring BZ, Seitz RS, Paik S, Costantino JP, Wolmark N.

Clin Cancer Res. 2008 Oct 15;14(20):6602-9. doi: 10.1158/1078-0432.CCR-08-0647.

14.

Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer.

Hanker AB, Morita S, Repasky GA, Ross DT, Seitz RS, Der CJ.

Methods Enzymol. 2008;439:53-72. doi: 10.1016/S0076-6879(07)00405-3.

PMID:
18374156
15.

Gene expression patterns within cell lines are predictive of chemosensitivity.

Ring BZ, Chang S, Ring LW, Seitz RS, Ross DT.

BMC Genomics. 2008 Feb 8;9:74. doi: 10.1186/1471-2164-9-74.

16.

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.

Espinosa I, Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, Varma S, Corless CL, Heinrich MC, Smith KS, Wang Z, Rubin B, Nielsen TO, Seitz RS, Ross DT, West RB, Cleary ML, van de Rijn M.

Am J Surg Pathol. 2008 Feb;32(2):210-8. doi: 10.1097/PAS.0b013e3181238cec.

PMID:
18223323
17.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S.

Mod Pathol. 2007 Jan;20(1):76-83. Epub 2006 Sep 29.

18.

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

Ring BZ, Seitz RS, Beck R, Shasteen WJ, Tarr SM, Cheang MC, Yoder BJ, Budd GT, Nielsen TO, Hicks DG, Estopinal NC, Ross DT.

J Clin Oncol. 2006 Jul 1;24(19):3039-47.

PMID:
16809728
19.

Predicting the sites of metastases.

Ring BZ, Ross DT.

Genome Biol. 2005;6(12):241. Epub 2005 Dec 2. Review.

20.

Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.

Troxell ML, Schwartz EJ, van de Rijn M, Ross DT, Warnke RA, Higgins JP, Natkunam Y.

Appl Immunohistochem Mol Morphol. 2005 Dec;13(4):297-303.

PMID:
16280657
21.

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer.

Gusterson BA, Ross DT, Heath VJ, Stein T.

Breast Cancer Res. 2005;7(4):143-8. Epub 2005 May 5. Review.

22.

Synthesis, molecular modeling and biological evaluation of aza-proline and aza-pipecolic derivatives as FKBP12 ligands and their in vivo neuroprotective effects.

Wilkinson DE, Thomas BE 4th, Limburg DC, Holmes A, Sauer H, Ross DT, Soni R, Chen Y, Guo H, Howorth P, Valentine H, Spicer D, Fuller M, Steiner JP, Hamilton GS, Wu YQ.

Bioorg Med Chem. 2003 Nov 3;11(22):4815-25.

PMID:
14556798
23.

Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1.

Smith KS, Chanda SK, Lingbeek M, Ross DT, Botstein D, van Lohuizen M, Cleary ML.

Mol Cell. 2003 Aug;12(2):393-400.

24.

Gene expression patterns in ovarian carcinomas.

Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI.

Mol Biol Cell. 2003 Nov;14(11):4376-86. Epub 2003 Sep 5.

25.

Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells.

Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH Jr.

Blood. 2003 Jul 1;102(1):237-45. Epub 2003 Feb 13.

PMID:
12586626
26.

Synthesis of N-glyoxyl prolyl and pipecolyl amides and thioesters and evaluation of their in vitro and in vivo nerve regenerative effects.

Hamilton GS, Wu YQ, Limburg DC, Wilkinson DE, Vaal MJ, Li JH, Thomas C, Huang W, Sauer H, Ross DT, Soni R, Chen Y, Guo H, Howorth P, Valentine H, Liang S, Spicer D, Fuller M, Steiner JP.

J Med Chem. 2002 Aug 1;45(16):3549-57.

PMID:
12139466
27.

Microarrays and molecular markers for tumor classification.

Ring BZ, Ross DT.

Genome Biol. 2002;3(5):comment2005. Epub 2002 Apr 29. Review.

28.

Solid-phase synthesis of FKBP12 inhibitors: N-sulfonyl and N-carbamoylprolyl/pipecolyl amides.

Wei L, Wu Y, Wilkinson DE, Chen Y, Soni R, Scott C, Ross DT, Guo H, Howorth P, Valentine H, Liang S, Spicer D, Fuller M, Steiner J, Hamilton GS.

Bioorg Med Chem Lett. 2002 May 20;12(10):1429-33.

PMID:
11992791
29.

Use of parallel-synthesis combinatorial libraries for rapid identification of potent FKBP12 inhibitors.

Choi C, Li JH, Vaal M, Thomas C, Limburg D, Wu YQ, Chen Y, Soni R, Scott C, Ross DT, Guo H, Howorth P, Valentine H, Liang S, Spicer D, Fuller M, Steiner J, Hamilton GS.

Bioorg Med Chem Lett. 2002 May 20;12(10):1421-8.

PMID:
11992790
30.
31.

Towards a novel classification of human malignancies based on gene expression patterns.

Alizadeh AA, Ross DT, Perou CM, van de Rijn M.

J Pathol. 2001 Sep;195(1):41-52. Review.

PMID:
11568890
33.

The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats.

Ross DT, Guo H, Howorth P, Chen Y, Hamilton GS, Steiner JP.

Neurosci Lett. 2001 Jan 12;297(2):113-6.

PMID:
11121883
34.

Molecular portraits of human breast tumours.

Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D.

Nature. 2000 Aug 17;406(6797):747-52.

PMID:
10963602
35.

Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.

Rusiniak ME, Yu M, Ross DT, Tolhurst EC, Slack JL.

Cancer Res. 2000 Apr 1;60(7):1824-9.

36.

A gene expression database for the molecular pharmacology of cancer.

Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, Weinstein JN.

Nat Genet. 2000 Mar;24(3):236-44.

PMID:
10700175
37.

Systematic variation in gene expression patterns in human cancer cell lines.

Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO.

Nat Genet. 2000 Mar;24(3):227-35.

PMID:
10700174
38.

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D.

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9212-7.

39.

Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes.

Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ.

Nucleic Acids Res. 1999 Mar 15;27(6):1517-23.

40.

Experimental investigation of cerebral contusion: histopathological and immunohistochemical evaluation of dynamic cortical deformation.

Shreiber DI, Bain AC, Ross DT, Smith DH, Gennarelli TA, McIntosh TK, Meaney DF.

J Neuropathol Exp Neurol. 1999 Feb;58(2):153-64.

PMID:
10029098
41.

The transcriptional program in the response of human fibroblasts to serum.

Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO.

Science. 1999 Jan 1;283(5398):83-7.

42.

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.

Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li JH, Huang W, Howorth P, Soni R, Fuller M, Sauer H, Nowotnik AC, Suzdak PD.

Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2019-24.

43.

Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: characterization by magnetization transfer ratio with histopathologic correlation.

Kimura H, Meaney DF, McGowan JC, Grossman RI, Lenkinski RE, Ross DT, McIntosh TK, Gennarelli TA, Smith DH.

J Comput Assist Tomogr. 1996 Jul-Aug;20(4):540-6.

PMID:
8708052
44.

The AMPA antagonist NBQX provides partial protection of rat cerebellar Purkinje cells after cardiac arrest and resuscitation.

Brasko J, Rai P, Sabol MK, Patrikios P, Ross DT.

Brain Res. 1995 Nov 13;699(1):133-8.

PMID:
8616603
45.

Biomechanical analysis of experimental diffuse axonal injury.

Meaney DF, Smith DH, Shreiber DI, Bain AC, Miller RT, Ross DT, Gennarelli TA.

J Neurotrauma. 1995 Aug;12(4):689-94.

PMID:
8683620
46.
48.

Modification of the cortical impact model to produce axonal injury in the rat cerebral cortex.

Meaney DF, Ross DT, Winkelstein BA, Brasko J, Goldstein D, Bilston LB, Thibault LE, Gennarelli TA.

J Neurotrauma. 1994 Oct;11(5):599-612.

PMID:
7861451
49.

Distribution of forebrain diffuse axonal injury following inertial closed head injury in miniature swine.

Ross DT, Meaney DF, Sabol MK, Smith DH, Gennarelli TA.

Exp Neurol. 1994 Apr;126(2):291-9.

PMID:
7925827
50.

Gopal Das 1933-1991. A remembrance.

Ross DT.

J Neural Transplant Plast. 1994 Apr-Jun;5(2):81-7. No abstract available.

Supplemental Content

Support Center